文献速递鼻科

保留梨状孔的改良内镜Denker术后并发症与临床结局的前瞻性分析

Complications and Clinical Outcomes Following Modified Endoscopic Denker's With Pyriform Aperture Preservation: A Prospective Analysis.
PubMed 文献 · Int Forum Allergy Rhinol · 2026-06-12

本研究前瞻性纳入52例接受保留梨状孔的改良内镜Denker术(MEDPAP)的成人患者,随访至少1年。结果显示MEDPAP对良性和部分恶性上颌窦病变管理成功率为100%,非肿瘤病变和肿瘤复发率均为0%;常见暂时性溢泪和颌面部感觉减退多在术后2-6个月缓解,持续性溢泪和感觉减退分别占7.7%和12%,无鼻阀塌陷或空鼻综合征发生。

要点

  • MEDPAP术后溢泪多为暂时性,中位63天缓解,持续性者占7.7%。
  • 术后感觉减退或麻木主要累及牙齿、上唇、鼻侧壁和面颊,多在2-6个月恢复。
  • 无患者发生鼻阀塌陷或空鼻综合征,最终ENS6Q中位数为0.5。

核心结论

  • MEDPAP在研究期间对良性和部分恶性上颌窦病变的管理成功率为100%。
  • 术后常见暂时性溢泪和颌面部感觉减退或麻木,多在术后2-6个月缓解。
  • 持续性溢泪和感觉减退分别占7.7%和12%,无鼻阀塌陷或空鼻综合征发生。

研究设计与样本

  • 前瞻性研究,纳入52例接受MEDPAP的成人患者,中位年龄58.5岁,55.8%为男性,随访至少1年(感觉减退随访2年)。

主要发现

  • 34.6%患者术后出现溢泪,其中7.7%持续存在;溢泪缓解中位时间为63.0天。
  • 术后感觉减退或麻木初始部位包括牙齿(23%-50%)、上唇(42%)、鼻部(22%)和面颊(30%),各部位缓解中位时间89.5-167.0天,88%-100%缓解。
  • 12%患者感觉减退持续存在(主要在前牙);结痂97.8%缓解,中位时间91.0天。
  • 无患者发生鼻阀塌陷,最终ENS6Q中位数为0.5(范围0-8)。
  • 非肿瘤病变和肿瘤复发率均为0%。

临床怎么用

  • MEDPAP可用于处理良性和部分恶性上颌窦病变,术后需向患者告知暂时性溢泪和颌面部感觉减退的可能。
  • 术后溢泪和感觉减退多在2-6个月内缓解,持续性溢泪和感觉减退比例较低。
  • MEDPAP术后鼻阀塌陷和空鼻综合征风险低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The modified endoscopic Denker's (MED) approach provides access to all maxillary sinus (MS) walls for resection of various MS and retromaxillary pathologies, but the anteromedial maxilla has historically been resected. This study determined complication rates and outcomes following MED with pyriform aperture (PA) preservation (MEDPAP). METHODS: A prospective study was conducted on all adults who underwent MEDPAP for different MS or retromaxillary pathologies over 7.5 years. The following complications were collected at all postoperative visits: epiphora, hypesthesia or complete numbness (teeth, upper lip, lateral nasal sidewall, and cheek), crusting, nasal valve collapse (NVC), and empty nose syndrome 6-item questionnaire (ENS6Q). Complications and disease recurrence rates were determined at a minimum 1 year for most complications and outcomes and 2 years for hypesthesia if hypesthesia had not resolved. RESULTS: Of 52 MEDPAP patients, median age was 58.5 years; 55.8% were male. Of 34.6% who experienced epiphora postoperatively, 7.7% persisted. When epiphora resolved, it did so by median 63.0 days. Sites of initial postoperative hypesthesia or numbness included teeth (23%-50%), upper lip (42%), nasal (22%), and cheek (30%). Hypesthesia resolved in 88%-100% of subsites by median 89.5-167.0 days. Hypesthesia persisted in 12% of patients (mainly anterior teeth). Crusting resolved in 97.8% by median 91.0 days. No patients developed NVC, and median final ENS6Q = 0.5 (range = 0-8). Non-tumor disease and tumor recurrence rates were 0%. CONCLUSIONS: MEDPAP was 100% successful at managing benign and select malignant MS pathologies during the study period. MEDPAP patients frequently experienced temporary epiphora and dentofacial hypesthesia or numbness that resolved by 2-6 months postoperatively. Epiphora and hypesthesia or numbness persisted in 7.7% and 12% of patients, respectively. No patients developed NVC or ENS.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Almansour Y, Donaldson L, Kashlan K, et al. Complications and Clinical Outcomes Following Modified Endoscopic Denker's With Pyriform Aperture Preservation: A Prospective Analysis. Int Forum Allergy Rhinol. 2026. PMID: 42283092. doi:10.1002/alr.70200

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。